NYSE:ENZ
Enzo Biochem Inc Stock News
$1.16
+0.0300 (+2.65%)
At Close: Jun 14, 2024
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up
02:20pm, Friday, 14'th Jun 2024
Enzo Biochem's (ENZ) overall topline benefits from revenue growth in the majority of its geographic regions.
Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
04:20pm, Thursday, 13'th Jun 2024
FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 202
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
04:26pm, Wednesday, 13'th Mar 2024
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
08:30am, Thursday, 01'st Feb 2024
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meetin
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
04:20pm, Friday, 15'th Dec 2023
FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023.
Steven J. Pully Appointed to Enzo Biochem's Board of Directors
04:15pm, Monday, 30'th Oct 2023
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been app
Enzo Biochem: Cleaned Up And Cash-Rich But Unloved
01:18am, Thursday, 26'th Oct 2023
Enzo Biochem is a microcap company with a $30 million revenue run-rate Life Sciences business and $78-$85 million in cash. The company is likely being prepared for sale, with interest from potential a
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
08:30am, Wednesday, 06'th Sep 2023
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Dire
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
04:27pm, Monday, 24'th Jul 2023
Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has clo
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
07:21pm, Wednesday, 14'th Jun 2023
- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences and
Federman & Sherwood Investigates Enzo Biochem for Data Breach
01:15pm, Friday, 02'nd Jun 2023
OKLAHOMA CITY--(BUSINESS WIRE)-- #DataBreach--The law firm of Federman & Sherwood has initiated an investigation into Enzo Biochem with respect to their recent data breach. On May 30, 2023, Enzo Bioch
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
09:20am, Monday, 22'nd May 2023
FARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), announced today that the preliminary voting results from the Inspector of Election at today's Special Meeting of the
SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.
08:30pm, Tuesday, 02'nd May 2023
NEW YORK , May 2, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enzo Biochem, Inc. ("Enzo Biochem" or th
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
04:05pm, Monday, 24'th Apr 2023
FARMINGDALE, NY, April 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo Biochem” or the “Company”), a leading biosciences and diagnostics company, today announced that its sp
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
09:43am, Tuesday, 21'st Mar 2023
- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division